Abbott Laboratories (NY:ABT)

The market can be a tricky place. Bet on these cash cow stocks to help restore confidence and extract steady returns.

Peering Into Abbott Laboratories's Recent Short Interest ↗

February 20, 2024

Via Benzinga

3 Cash Cows to Boost Your Confidence During the February Chill ↗

February 18, 2024

These stocks reward you during any market environment.

The Smartest Dividend Stocks to Buy With $400 Right Now ↗

February 18, 2024

Cardiology's Quantum Leap: FDA's Advisory Panel Gives Thumbs Up To Abbott's Minimally Invasive Heart Valve Repair Device ↗

February 14, 2024

FDA panel confirms support (13-1) for Abbott Laboratories' TriClip TEER system in treating tricuspid regurgitation. Approval decision expected from FDA in 2024.

Via Benzinga

FDA Advisors Set To Discuss Abbott's TriClip For Heart Valve Disorder As Questions On Pivotal Trial Loom ↗

February 12, 2024

FDA to review Abbott's TriClip G4 System for severe tricuspid regurgitation. Circulatory System Devices Panel meeting and insights from the briefing document.

Via Benzinga

This Is What Whales Are Betting On Abbott Laboratories ↗

February 08, 2024

Via Benzinga

Is Abbott Laboratories Stock a Buy Now? ↗

February 03, 2024

Can Abbott Laboratories be a reliable income stock to hang on to now?

Abbott Laboratories Is the Latest Company to Get Involved in the Weight Loss Market. Here's How. ↗

Looking At Abbott Laboratories's Recent Unusual Options Activity ↗

January 30, 2024

Via Benzinga

February 11, 2024

Abbott Labs has an impressive portfolio of nutrition drinks, and its latest addition could help it profit from a new market: people taking prescribed weight loss drugs.

Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.

3 Groundbreaking Healthcare Stocks to Buy for Robust Gains ↗

February 11, 2024

There's room for multiple winners in the fast-growing weight-loss market.

These 2 Stocks Are Trying to Ride the Ozempic Bandwagon: Are They Buys? ↗

February 09, 2024

Abbott Laboratories shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Abbott Laboratories Stock Getting Closer To Key Technical Benchmark ↗

February 07, 2024

When it comes to buying dividend stocks, investors should seek out companies that consistently and repliably grow their payout over time.

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates ↗

February 07, 2024

Healthcare is an excellent place to find some tried and true wealth compounders.

Looking Into Abbott Laboratories's Recent Short Interest ↗

January 26, 2024

Via Benzinga

Cracking The Code: Understanding Analyst Reviews For Abbott Laboratories ↗

January 25, 2024

Via Benzinga

Want to Get Richer? Here Are the 3 Best Stocks to Buy Now and Hold Forever ↗

February 07, 2024

Healthcare stocks usually provide a defensive posture to a stock portfolio.

Healthcare And Life Science Funds And ETFs Performance 2023-2024 ↗

February 05, 2024

Via Talk Markets

Topics ETFs

2 Stocks to Buy Near Their 52-Week Highs ↗

February 05, 2024

It's not too late to invest in these stocks.

It's going to take a lot to interrupt these companies' streaks.

2 Healthcare Dividend Kings to Buy and Hold Forever ↗

February 04, 2024

Abbott Laboratories faces a lawsuit questioning the efficacy of PediaSure Grow & Gain nutrition drinks in promoting height growth.

Abbott Faces Lawsuit As Grandmother Questions PediaSure's Height Growth Claims ↗

February 03, 2024

Via Benzinga

Topics Lawsuit

Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market? ↗

February 02, 2024

Abbott Labs is using its well-established strengths to make gains in the weight loss market.

Aging is an inevitability, as much as we try to deny it. Under this context, these AgeTech stocks may prove quite relevant.

7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market ↗

January 28, 2024

Stock Market Continues To Rally; ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review ↗

January 26, 2024

The S&P 500 and Dow Jones hit fresh record highs on Friday.

World's Smallest Brain Stimulation Device For Movement Disorder: FDA Approved Abbott's Liberta RC DBS system ↗

Topics Stocks

January 25, 2024

Abbott's Liberta RC DBS system, the world's smallest FDA-approved rechargeable deep brain stimulation device. With only 10 recharges a year, it's compatible with NeuroSphere Virtual Clinic, reducing...

Via Benzinga

Stock Market Extends Record Highs, S&P 500 Hits 4,900 On Tech Rally, Microsoft's $3 Trillion Mark: What's Driving Markets Wednesday? ↗

January 24, 2024

It’s a bullish day on Wall Street, with major U.S. large-cap indices reaching record highs, driven by broad-based rallies in tech-related stocks as investors continue to embrace the AI trade.

Via Benzinga

Topics Artificial Intelligence Stocks

Abbott Laboratories (ABT) Q4 2023 Earnings Call Transcript ↗

January 24, 2024

ABT earnings call for the period ending December 31, 2023.

Abbott Laboratories Surpasses Q4 Sales Expectations, Despite Dip In COVID-19 Testing Demand ↗

Topics Earnings

January 24, 2024

Abbott Laboratories exceeds expectations with Q4 sales of $10.24B, showcasing resilience despite softer demand for COVID-19 testing. CEO anticipates continued growth in 2024.

Via Benzinga

Abbott Labs Skids On Light Earnings Guidance Despite Quarterly Sales Beat ↗

January 24, 2024

Abbott beat sales expectations and earnings came in light for the fourth quarter.